The cholesteryl ester transfer protein (CETP) TaqIB polymorphism in the cholesterol and recurrent events study: no interaction with the response to pravastatin therapy and no effects on cardiovascular outcome: a prospective analysis of the CETP TaqIB polymorphism on cardiovascular outcome and interaction with cholesterol-lowering therapy.
Source:http://linkedlifedata.com/resource/pubmed/id/14998629
J. Am. Coll. Cardiol.
2004
Mar
3
43
5
854-7
